Bioprinting · 2024
mSLAb–An open-source masked stereolithography (mSLA) bioprinter
3D bioprinting is a tissue engineering approach using additive manufacturing to fabricate tissue equivalents for regenerative medicine or medical drug testing. For this purpose, biomaterials that provide the essential microenvironment to support the viability of cells integrated directly or seeded after printing are processed into three-dimensional (3D) structures.
Performance the paper reports
0 of 5- Motion—Motion accuracy: not reported
- Volume—Volumetric accuracy: not reported
- Viability—Cell viability: not reported
- Unattended—Unattended operation: not reported
- Standard—Standard compliance: not reported
The full text was read and states no figure for any of the five.
How hard this is to adopt
3.4 of 5, higher is easierEach score is shown against the range the other 59 builds actually occupy, because no criterion uses the full 1–5 scale. These describe how reproducible the build is, not how good the science is.
Resolution
4/1–5printing resolution evidence suggests 50 µm.
Throughput
2/2–5Operation appears single-unit or manually constrained.
Parts sourcing
4/2–4Mostly off-the-shelf or kit-based components.
Skill needed
4/2–4Build/operation described as low-skill or basic assembly.
Facilities needed
4/2–4Uses common benchtop/desktop equipment or generic consumables.
Documentation
4/2–5Open resources include several build or operation artifacts.
Validation effort
2/2–4Minimal quantitative validation evident, lacks standards, benchmarking, replicates or multi-condition tests.
Cycle time
not scoredNo speed envidence.
2 further criteria are recorded but not shown
- Application Level — scored 2 (75% of records share one value), so it cannot separate one build from another.
- Build Time (scored for only 6 of 60 records), so it cannot separate one build from another.
Both remain in the published dataset.
Have you built this?
Report what it took, including attempts that stalled. A failed build tells the next laboratory what the documentation leaves out.
Know what this record is missing?
The index has no link to the design files or which files exist (CAD, bill of materials, firmware…) for this build. If you are an author or have built it, you know; a GitHub issue pre-filled with this record takes a minute.
Record metadata
Publication data
Matched by title · retrieved 2026-07-21
Abstract
3D bioprinting is a tissue engineering approach using additive manufacturing to fabricate tissue equivalents for regenerative medicine or medical drug testing. For this purpose, biomaterials that provide the essential microenvironment to support the viability of cells integrated directly or seeded after printing are processed into three-dimensional (3D) structures. Compared to extrusion-based 3D printing, which is most commonly used in bioprinting, stereolithography (SLA) offers a higher printing resolution and faster processing speeds with a wide range of cell-friendly materials such as gelatin- or collagen-based hydrogels and SLA is, therefore, well suited to generate 3D tissue constructs. While there have been numerous publications of conversions and upgrades for extrusion-based printers, this is not the case for state-of-the-art SLA technology in bioprinting. The high cost of proprietary printers severely limits teaching and research in SLA bioprinting. With mSLAb, we present a low-cost and open-source high-resolution 3D bioprinter based on masked SLA (mSLA). mSLAb is based on an entry-level (€350) desktop mSLA printer (Phrozen Sonic Mini 4 K), equipped with temperature control and humidification of the printing chamber to enable the processing of cell-friendly hydrogels. Additionally, the build platform was redesigned for easy sample handling and microscopic analysis of the printed constructs. All modifications were done with off-the-shelf hardware and in-house designed 3D printed components, printed with the same printer that was being modified. We validated the system by printing macroscopic porous scaffolds as well as hollow channels from gelatin-based hydrogels as representative structures needed in tissue engineering.
Bibliographic details
Access and metrics
Topics and keywords
Funding
- German Research Foundation · 512819356
- Bavarian State Ministry for Science and Art
- Bavarian Academic Forum
Perspective and practical signals
Why it matters
No narrative note curated yet.
Limitations
No limitation note curated yet.